January 16, 2006 -- Big pharma is in the dumps, according to popular wisdom. Indeed, some of the biggest names in pharma have watched their stock prices skid steadily lower. Nonetheless, some pharma like Bayer and AstraZeneca, managed to post solid double-digit percentage gains last year – despite the popular wisdom. Wyeth also performed quite well in 2005, adding almost 10%, despite its famously troubled past. We look at the drugs from Wyeth - present and future - to see if the momentum will continue to build...